AstraZeneca Pharma India To Launch Cancer Drug
AstraZeneca 100mg tablets, produced by AstraZeneca Plc. (Photographer: Simon Dawson/Bloomberg)

AstraZeneca Pharma India To Launch Cancer Drug

Bookmark

Drugmaker AstraZeneca Pharma India Ltd. on Thursday said it will launch its Acalabrutinib 100 milligram capsules, used for treatment of various types of blood cancers, under the brand name 'Calquence' in the country on Oct. 21.

The capsules are indicated for treatment of patients with mantle cell lymphoma who have received at least one prior therapy and for treatment of patients with chronic lymphocytic leukaemia and small lymphocytic lymphoma, AstraZeneca Pharma India said in a filing to the stock exchanges.

Also read: AstraZeneca’s Covid Antibody Drug Heads Into Advanced Trials

Shares of AstraZeneca Pharma India Ltd. on Thursday closed 0.61% lower at Rs 4,266.65 apiece on the BSE.

BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.